Rankings
▼
Calendar
VCEL Q2 2016 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q2 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$13M
Gross Profit
$6M
43.1% margin
Operating Income
-$5M
-38.9% margin
Net Income
-$3M
-23.7% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
-9.1%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$831,000
Balance Sheet
Total Assets
$29M
Total Liabilities
$12M
Stockholders' Equity
$17M
Cash & Equivalents
$10M
← FY 2016
All Quarters
Q3 2016 →